• Astellas Pharma average ebitda margin for 2023 was 19.74%, a 11.12% decline from 2022.
• Astellas Pharma average ebitda margin for 2022 was 22.21%, a 6.21% decline from 2021.
• Astellas Pharma average ebitda margin for 2021 was 23.68%, a 2.03% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.